Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 2307-2315, November 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bekesi, J. G.
Right arrow Articles by Bice, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bekesi, J. G.
Right arrow Articles by Bice, S.

The Metabolism of Plasma Glycoproteins

II. Studies on the Rate of Incorporation of Glucosamine-1-14C into Protein-bound Hexosamine in the Rat Bearing Walker 256 Carcinoma1

J. G. Bekesi2, R. A. L. Macbeth and S. Bice

Department of Surgery and the Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada

The origin of the elevated serum glycoproteins observed in rats bearing 6- and 12-day-old Walker 256 carcinoma has been studied utilizing glucosamine-1-14C as a precursor. The results indicate that the liver is quantitatively the major site of serum glycoprotein biosynthesis as is the case in the normal animal. While the rate of incorporation of glucosamine-1-14C into hepatic protein-bound hexosamine was not altered from normal in the early stages of tumor development, the 12-day-old Walker carcinoma provoked a significant increase in the hepatic binding of glucosamine-1-14C. In both tumor age groups the biologic half-life of the hepatic protein-bound hexosamine was longer than in normal animals.

In vivo studies following hepatectomy, with and without isolation of the tumor, and in vitro studies would strongly suggest that the tumor too is metabolically active with respect to glycoprotein biosynthesis and release. Furthermore, the rate of synthesis appears to depend on the volume of viable tumor rather than its age.

Evidence is presented which indicates that, in tumor bearing rats, the biosynthesis of the seromucoid fraction is significantly increased. In tumor bearing rats seromucoid synthesis represents 23–27% of the total serum glycoprotein synthesized as compared with a figure of 8.9% for normal animals. The biologic half-life of both the total serum glycoprotein and the seromucoid fraction is, however, significantly shorter in tumor bearing than it is in normal rats.

Analysis of the urine in both tumor age groups revealed that over 90% of the radioactivity that was recoverable in the urine was associated with free glycosamine and other as yet uncharacterized compounds.

The incorporation of administered glucosamine-1-14C into body tissues, other than liver and tumor, was minimal in comparison.

1 This work was supported by Grant 226 from the National Cancer Institute of Canada.

2 Present address: Department of Biochemistry, State University of New York, Buffalo, New York.

Received 2/ 2/66. Accepted 5/25/66.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.